Exicure (XCUR) Amortizatization of Intangibles (2020 - 2022)
Exicure's (XCUR) quarterly Amortizatization of Intangibles came in at $1000.0 in Q2 2022, up 101.59% YoY from $496.06 in Q2 2021, and little changed on a QoQ basis from $1000.0 in Q1 2022.
Exicure (XCUR) Amortizatization of Intangibles (2020 - 2022) Analysis & Trends
Exicure (XCUR) has 3 years of Amortizatization of Intangibles data on file, last reported at $1000.0 in Q2 2022.
- Quarterly Amortizatization of Intangibles rose 101.59% year-over-year to $1000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $1000.0 (up 101.33% YoY) and the FY2022 annual result came in at $2000.0, up 101.09% from the prior year.
- Amortizatization of Intangibles held at $1000.0 in Q2 2022, from $1000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1000.0 in Q1 2022 to a low of -$117000.0 in Q4 2020.
- A 3-year average of -$50100.0 and a median of -$47500.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles sank 170.0% — and 2022, when it jumped 101.59%.
- Tracing XCUR's Amortizatization of Intangibles over 3 years: stood at -$117000.0 in 2020, then surged by 99.15% to -$1000.0 in 2021, then surged by 200.0% to $1000.0 in 2022.
- The last three Amortizatization of Intangibles figures came in at $1000.0 (Q2 2022), $1000.0 (Q1 2022), and -$1000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -63,000.00 |
| Jun 30, 2021 | -63,000.00 |
| Mar 31, 2021 | -108,000.00 |
| Mar 31, 2021 | -108,000.00 |
| Dec 31, 2020 | -117,000.00 |
| Dec 31, 2020 | -117,000.00 |
| Sep 30, 2020 | -107,000.00 |
| Sep 30, 2020 | -107,000.00 |
| Jun 30, 2020 | -55,000.00 |
| Jun 30, 2020 | -55,000.00 |
| Mar 31, 2020 | -40,000.00 |
| Mar 31, 2020 | -40,000.00 |